Article
Current treatment of severe asthma.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology - 1 May 2012
Hashimoto S, Bel E H
Abstract excerpt
Severe asthma is considered a heterogeneous disease in which a variety of clinical, physiological and inflammatory markers determine disease severity. Pivotal studies in the last 5 years have led to substantial progress in many areas, ranging from a more accurate definition of truly severe, refractory asthma, to classification of the disease into distinct clinical phenotypes, and introduction of new therapies....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.